Home
About
Overview
Sharing Data
ORCID
Help
History (52)
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016.
Artificial Limbs
High-Throughput Screening Assays
Genetic architecture of regulatory variation in Arabidopsis thaliana.
Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model.
See All 52 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model.
Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model. Gene Ther. 2003 Feb; 10(3):206-12.
View in:
PubMed
subject areas
Adenocarcinoma
Adenoviridae
Animals
Combined Modality Therapy
Esophageal Neoplasms
Genetic Therapy
Genetic Vectors
Green Fluorescent Proteins
Humans
Luminescent Proteins
Mice
Mice, Nude
Models, Animal
Mucin-1
Peptide Fragments
Promoter Regions, Genetic
Random Allocation
Transplantation, Heterologous
Tumor Cells, Cultured
Tumor Necrosis Factor-alpha
Virus Replication
authors with profiles
Nora Jaskowiak
Ralph Weichselbaum
Mitchell Posner